ASIA-PACIFIC 3D BIOPRINTING MARKET FORECAST 2023-2032
The Asia-Pacific 3D bioprinting market is projected to register a CAGR of 16.81% during the forecast period, 2023-2032, and is set to garner a revenue of $1382.46 million by 2032.
ASIA-PACIFIC 3D BIOPRINTING MARKET FORECAST 2023-2032
Asia-Pacific 3D Bioprinting Market by Component (3d Bioprinter, Bioink) Market by Biomaterial (Hydrogel, Living Cells, Extracellular Matrices, Other Biomaterials) Market by Technology (Magnetic Levitation Bioprinting, Inkjet-based Bioprinting, Syringe/extrusion-based Bioprinting, Laser-assisted Bioprinting, Other Technologies) Market by Application (Drug Testing & Development, Tissue Engineering & Regenerative Medicine, Food Testing, Research, Other Applications) Market by End-user (Hospitals, Biopharmaceuticals Companies, Research Organizations and Academic Institutes, Other End-users) by Geography
The Asia-Pacific 3D bioprinting market is projected to register a CAGR of 16.81% during the forecast period, 2023-2032, and is set to garner a revenue of $1382.46 million by 2032.
The 3D bioprinting market growth in Asia-Pacific is attributed to ongoing, active regenerative medicine research, especially in cell therapy, tissue engineering, and gene therapy. This is due to the unmet needs and health burden in several countries of the region. The growing geriatric population, the emergence of personalized medicine, and the transplant requirements per organ donation are among the important growth drivers in the region.
However, the Asia-Pacific 3D bioprinting market growth is hindered by technological limitations and a lack of regulatory framework.
To know more about this report, request a free sample copy
The Asia-Pacific 3D bioprinting market growth analysis includes the assessment of Singapore, Thailand, Japan, India, China, South Korea, Australia & New Zealand, and Rest of Asia-Pacific. Japan has gained prominence in technological advancements and research in Asia. Accordingly, it is witnessing fast-paced developments in its 3D printing industry, given the rising demand across end-user industries. Also, the healthcare and manufacturing industries are increasingly inclined toward 3D printing technology, experimenting with several 3D printing techniques, 3D printers, and alternative manufacturing mechanisms.
Further, as per government estimates, the regenerative medicine industry is expected to reach JPY 1 trillion by 2030. The New Energy and Industrial Technology Development Organization (NEDO) has evaluated a leading position for 3D bioprinting in research and development for the future. In addition, the rising incidences of chronic illnesses resulting in tissue & organ transplants and a restricted number of organ donors offer growth opportunities for the market analyzed.
In South Korea, the government is set to invest around $37 million to boost 3D printing. The strategic collaborations among 3D printing technology providers and industry players at regional and global levels are estimated to enable growth opportunities. Also, the country is increasingly focusing on the convergence of computer engineering, mechanical engineering, and medicine. As a result, research and development activities on 3D bioprinting are highly prioritized.
The Asia-Pacific 3D bioprinting market segmentation includes end-user, application, technology, biomaterial, and component. The end-user segment includes research organizations and academic institutes, biopharmaceutical companies, hospitals, and other end-users.
With regard to the pharmaceutical manufacturing industry, bioprinting can transform drug-making beyond manufacturing tablets. 3D bioprinters can help make headways in areas that restrict progress for pharma. For instance, 2D cell culture methods and traditional animal models. Also, bioprinted tissues may help accelerate the drug discovery process and facilitate R&D teams to assess new drugs on functional human tissues during lead optimization and hit-to-lead stages of drug development. This will further help identify potential efficacy and toxicity issues before drugs enter clinical studies.
Furthermore, 3D bioprinting has several applications in pharmaceutical and biomedical applications. Many pharmaceutical companies have partnered with research institutions, universities, and organizations like Organovo to create 3D-printed cardiac, skin, and liver tissues.
Moreover, prosthetic technology has undergone only a few changes. Additionally, prosthetics are expensive. In this regard, 3D-printed prosthetics offer a solution since they are cost-effective and stable. For instance, graphene prosthetics have greater natural functioning and durability.
Some of the eminent firms in the Asia-Pacific 3D bioprinting market are GeSiM GmbH, Regemat 3D, Organovo Holdings Inc, ROKIT Healthcare Inc, etc.
ROKIT Healthcare Inc is a bioprinting & biotechnology company based in South Korea. It specializes in the development of clinical kits that include medical operation technologies, biomaterials, software, and bioprinters. The company is headquartered in Seoul, South Korea, with operations in Asia, Europe, and North America.
One of its key products, Dr. INVIVO 4D6, is equipped with a built-in cell incubator CO₂ level control. It enables optimal cell growth environment for complex tissues and cells.
Report Synopsis
|
Report Scope |
Details |
| Market Forecast Years | 2023-2032 |
| Base Year | 2022 |
| Market Historical Years | 2018-2022 |
| Forecast Units | Revenue ($ Million) |
| Segments Analyzed | End-User, Application, Technology, Biomaterial, Component |
| Countries Analyzed | Singapore, Thailand, Japan, India, China, South Korea, Australia & New Zealand, and Rest of Asia-Pacific |
| Companies Analyzed |
3D Bioprinting Solutions, Advanced Solutions Life Sciences, Allevi, CELLINK, CollPlant Biotechnologies Ltd, Cyfuse Biomedical KK, EnvisionTEC Ṁ Inc, GeSiM GmbH, Inventia Life Science Pty Ltd, Organovo Holdings Inc, Regemat 3D, REGENHU, Revotek Co Ltd, ROKIT Healthcare Inc, Stratasys Ltd |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- IMPACT OF COVID-19 ON 3D BIOPRINTING MARKET
- MAJOR MARKET FINDINGS
- EMERGENCE OF 4D BIOPRINTING AS A SUBSTITUTE FOR 3D BIOPRINTING
- PERSONALIZED MEDICINE LIKELY TO BOOST 3D BIOPRINTING
- RISING INTEREST IN THE APPLICATION OF BIOPRINTING AGAINST THE SARS-COV-2 VIRUS
- MARKET DYNAMICS
- KEY DRIVERS
- SURGING GERIATRIC POPULATION
- TECHNOLOGICAL ADVANCEMENTS AND R&D INVESTMENTS
- RISING FOCUS ON REGENERATIVE MEDICINE
- HIGH PREVALENCE OF CHRONIC CONDITIONS
- KEY RESTRAINTS
- OPERATIONAL CHALLENGES DURING MANUFACTURING
- EXORBITANT COSTS OF 3D BIOPRINTERS
- LACK OF TRAINED PROFESSIONALS
- KEY DRIVERS
- KEY ANALYTICS
- PARENT MARKET ANALYSIS
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- GROWTH PROSPECT MAPPING IN CHINA
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
- VALUE CHAIN ANALYSIS
- DESIGN & SOFTWARE PROVIDERS
- PROTOTYPE PRODUCTION
- DISTRIBUTION
- END-USERS
- MARKET BY COMPONENT
- 3D BIOPRINTER
- BIOINK
- MARKET BY BIOMATERIAL
- HYDROGEL
- LIVING CELLS
- EXTRACELLULAR MATRICES
- OTHER BIOMATERIALS
- MARKET BY TECHNOLOGY
- MAGNETIC LEVITATION BIOPRINTING
- INKJET-BASED BIOPRINTING
- SYRINGE/EXTRUSION-BASED BIOPRINTING
- LASER-ASSISTED BIOPRINTING
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- DRUG TESTING & DEVELOPMENT
- TISSUE ENGINEERING & REGENERATIVE MEDICINE
- FOOD TESTING
- RESEARCH
- OTHER APPLICATIONS
- MARKET BY END-USER
- HOSPITALS
- BIOPHARMACEUTICALS COMPANIES
- RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- ASIA-PACIFIC 3D BIOPRINTING MARKET DRIVERS
- ASIA-PACIFIC 3D BIOPRINTING MARKET CHALLENGES
- ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN ASIA-PACIFIC 3D BIOPRINTING MARKET
- COUNTRY ANALYSIS
- CHINA
- CHINA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- JAPAN
- JAPAN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- INDIA
- INDIA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- SOUTH KOREA
- SOUTH KOREA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- SINGAPORE
- SINGAPORE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- THAILAND
- THAILAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- AUSTRALIA & NEW ZEALAND
- AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- REST OF ASIA-PACIFIC
- REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- CHINA
- ASIA-PACIFIC
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- COMPANY PROFILES
- 3D BIOPRINTING SOLUTIONS
- COMPANY OVERVIEW
- PRODUCTS LIST
- ADVANCED SOLUTIONS LIFE SCIENCES
- COMPANY OVERVIEW
- PRODUCTS LIST
- ALLEVI
- COMPANY OVERVIEW
- PRODUCTS LIST
- CELLINK
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- COLLPLANT BIOTECHNOLOGIES LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- CYFUSE BIOMEDICAL KK
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- ENVISIONTEC ṁ INC
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- GESIM GMBH
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- INVENTIA LIFE SCIENCE PTY LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- ORGANOVO HOLDINGS INC
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- REGEMAT 3D
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- REGENHU
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRENGTHS & CHALLENGES
- REVOTEK CO LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- ROKIT HEALTHCARE INC
- COMPANY OVERVIEW
- PRODUCTS LIST
- STRATASYS LTD
- COMPANY OVERVIEW
- PRODUCTS LIST
- 3D BIOPRINTING SOLUTIONS
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – 3D BIOPRINTING
TABLE 2: COMPARATIVE SUMMARY OF 3D BIOPRINTING TECHNOLOGIES
TABLE 3: LIST OF APPROVED TISSUE-ENGINEERED MEDICAL PRODUCTS (TEMPS) USED IN VARIOUS COUNTRIES
TABLE 4: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY BIOMATERIAL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY BIOMATERIAL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY APPLICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
TABLE 17: KEY PLAYERS OPERATING IN ASIA-PACIFIC 3D BIOPRINTING MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR CHINA
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: ASIA-PACIFIC 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
FIGURE 8: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY 3D BIOPRINTER, 2023-2032 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY BIOINK, 2023-2032 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY BIOMATERIAL, IN 2022
FIGURE 11: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY HYDROGEL, 2023-2032 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY LIVING CELLS, 2023-2032 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY EXTRACELLULAR MATRICES, 2023-2032 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY OTHER BIOMATERIALS, 2023-2032 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2022
FIGURE 16: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY MAGNETIC LEVITATION BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY INKJET-BASED BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY SYRINGE/EXTRUSION-BASED BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY LASER-ASSISTED BIOPRINTING, 2023-2032 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY OTHER TECHNOLOGIES, 2023-2032 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 22: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY DRUG TESTING & DEVELOPMENT, 2023-2032 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, 2023-2032 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY FOOD TESTING, 2023-2032 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY RESEARCH, 2023-2032 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY OTHER APPLICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC 3D BIOPRINTING MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 28: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY BIOPHARMACEUTICALS COMPANIES, 2023-2032 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES, 2023-2032 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC 3D BIOPRINTING MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC 3D BIOPRINTING MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 33: CHINA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 34: JAPAN 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 35: INDIA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: SOUTH KOREA 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: SINGAPORE 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 38: THAILAND 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET, 2023-2032 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- ASIA-PACIFIC
- MARKET SIZE & ESTIMATES
- ASIA-PACIFIC 3D BIOPRINTING MARKET DRIVERS
- ASIA-PACIFIC 3D BIOPRINTING MARKET CHALLENGES
- ASIA-PACIFIC 3D BIOPRINTING MARKET REGULATORY FRAMEWORK
- KEY PLAYERS IN ASIA-PACIFIC 3D BIOPRINTING MARKET
- COUNTRY ANALYSIS
- CHINA
- CHINA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- JAPAN
- JAPAN 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- INDIA
- INDIA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- SOUTH KOREA
- SOUTH KOREA 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- SINGAPORE
- SINGAPORE 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- THAILAND
- THAILAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- AUSTRALIA & NEW ZEALAND
- AUSTRALIA & NEW ZEALAND 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- REST OF ASIA-PACIFIC
- REST OF ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE & OPPORTUNITIES
- CHINA
- ASIA-PACIFIC
- MARKET BY COMPONENT
- 3D BIOPRINTER
- BIOINK
- MARKET BY BIOMATERIAL
- HYDROGEL
- LIVING CELLS
- EXTRACELLULAR MATRICES
- OTHER BIOMATERIALS
- MARKET BY TECHNOLOGY
- MAGNETIC LEVITATION BIOPRINTING
- INKJET-BASED BIOPRINTING
- SYRINGE/EXTRUSION-BASED BIOPRINTING
- LASER-ASSISTED BIOPRINTING
- OTHER TECHNOLOGIES
- MARKET BY APPLICATION
- DRUG TESTING & DEVELOPMENT
- TISSUE ENGINEERING & REGENERATIVE MEDICINE
- FOOD TESTING
- RESEARCH
- OTHER APPLICATIONS
- MARKET BY END-USER
- HOSPITALS
- BIOPHARMACEUTICALS COMPANIES
- RESEARCH ORGANIZATIONS AND ACADEMIC INSTITUTES
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.